SAUDI J GASTROENTERO 润色咨询

Saudi Journal of Gastroenterology

出版年份:暂无数据 年文章数:550 投稿命中率: 开通期刊会员,数据随心看

出版周期:Bimonthly 自引率:6.8% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2194922, encodeId=ffa3219492287, content=审稿速度:4.0 | 投稿命中率:50.0<br>经验分享:11.20投稿.3.21小修,3.23返回,有消息会说。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/iaqwic5175nrsPthItiav2krrGr1HkL2Gl7ibKMfiaxFDfk8ooX2wKVqzMMmDYZEhyD6bNYCouCkTg1zL6EhBr4cRPwH5icBgibpdbQ/0, createdBy=cc4f2072535, createdName=Latte2024, createdTime=Sat Mar 23 21:05:57 CST 2024, time=2024-03-23, status=1, ipAttribution=雪兰莪), GetPortalCommentsPageByObjectIdResponse(id=2192874, encodeId=663021928e4bb, content=非常慢,快4个月了,还在in peer review,问了编辑就说还没收到审稿人意见,为啥不能催催啊,一直耗着, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/iaqwic5175nrsPthItiav2krrGr1HkL2Gl7ibKMfiaxFDfk8ooX2wKVqzMMmDYZEhyD6bNYCouCkTg1zL6EhBr4cRPwH5icBgibpdbQ/0, createdBy=cc4f2072535, createdName=Latte2024, createdTime=Wed Mar 13 00:37:37 CST 2024, time=2024-03-13, status=1, ipAttribution=槟州), GetPortalCommentsPageByObjectIdResponse(id=575120, encodeId=76d15e512048, content=请问大神,投稿的时候就要传已经签名的copyright么?如果投稿的时候没传是不是两周之内要补上?能等编辑给消息了再补copyright吗。还是不传copyright稿件就不会审理?初次投稿,不太懂,感谢前辈的回复<span class="quote">zhangyuanyuan 2017-11-18 10:00:00 发表:<br>9.10号投稿.10.24暂时接收.11.14小修核对.11.17正式接收.总体来说还是很容易中的.虽然分数不高.但是第一篇sci顺利接收.还是很开心的.未来再接再厉!大家如果有消化科科研兴趣的.可以跟我多交流!</span>, beContent=zhangyuanyuan 2017-11-18 10:00:00 发表: 9.10号投稿.10.24暂时接收.11.14小修核对.11.17正式接收.总体来说还是很容易中的.虽然分数不高.但是第一篇sci顺利接收.还是很开心的.未来再接再厉!大家如果有消化科科研兴趣的.可以跟我多交流!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/12/583cfe768bfe1fa945460bb6b687441a.jpg, createdBy=4bcf2195510, createdName=王林林, createdTime=Wed Aug 21 00:00:00 CST 2019, time=2019-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590452, encodeId=d1fb5904524d, content=请问你两周之内补上了吗。我也遇到这个问题怕,谢谢<span class="quote">王林林 2019-08-21 00:00:00 发表:<br>请问一下,如果刚投稿,两周之内没有上传已签名的copyright,。会影响稿件的处理吗?</span>, beContent=王林林 2019-08-21 00:00:00 发表: 请问一下,如果刚投稿,两周之内没有上传已签名的copyright,。会影响稿件的处理吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=560e5151026, createdName=14697858m50(暂无昵称), createdTime=Fri May 08 00:00:00 CST 2020, time=2020-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1213222, encodeId=e0571213222bc, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享:比较好中吧,杂志挺好的<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6e461972408, createdName=罗磊, createdTime=Thu Apr 21 17:33:58 CST 2022, time=2022-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095044, encodeId=d6b920950440d, content=请问copyright怎么上传, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f52b2024392, createdName=爱学习的汪医生, createdTime=Thu Oct 20 21:24:38 CST 2022, time=2022-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2145084, encodeId=75e32145084ee, content=偏重的研究方向:消化性溃疡<br>经验分享:2023.05.11投了一篇meta分析,2023.06.27还没有消息,静待佳音,随时更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=40912029793, createdName=pcr小妹, createdTime=Tue Jun 27 20:57:40 CST 2023, time=2023-06-27, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2161998, encodeId=f1a22161998db, content=偏重的研究方向:慢性肝病研究<br>经验分享:under technical modification 是啥意思有人可以解惑嘛?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=606e8457349, createdName=ms4000001911305314, createdTime=Tue Oct 10 17:02:46 CST 2023, time=2023-10-10, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1208660, encodeId=cdc7120866050, content=偏重的研究方向:消化病<br>经验分享:投了一篇meta,挺好中的。纯生信就是耍流氓,影响别人后续实验的创新性!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=86225692711, createdName=ms6000001891961838, createdTime=Mon Apr 04 22:34:19 CST 2022, time=2022-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106011, encodeId=3e44110601152, content=什么样的图表可以用来发文章?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=)]
    2024-03-23 Latte2024 来自雪兰莪

    审稿速度:4.0 | 投稿命中率:50.0
    经验分享:11.20投稿.3.21小修,3.23返回,有消息会说。

    1

    展开1条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=2194922, encodeId=ffa3219492287, content=审稿速度:4.0 | 投稿命中率:50.0<br>经验分享:11.20投稿.3.21小修,3.23返回,有消息会说。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/iaqwic5175nrsPthItiav2krrGr1HkL2Gl7ibKMfiaxFDfk8ooX2wKVqzMMmDYZEhyD6bNYCouCkTg1zL6EhBr4cRPwH5icBgibpdbQ/0, createdBy=cc4f2072535, createdName=Latte2024, createdTime=Sat Mar 23 21:05:57 CST 2024, time=2024-03-23, status=1, ipAttribution=雪兰莪), GetPortalCommentsPageByObjectIdResponse(id=2192874, encodeId=663021928e4bb, content=非常慢,快4个月了,还在in peer review,问了编辑就说还没收到审稿人意见,为啥不能催催啊,一直耗着, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/iaqwic5175nrsPthItiav2krrGr1HkL2Gl7ibKMfiaxFDfk8ooX2wKVqzMMmDYZEhyD6bNYCouCkTg1zL6EhBr4cRPwH5icBgibpdbQ/0, createdBy=cc4f2072535, createdName=Latte2024, createdTime=Wed Mar 13 00:37:37 CST 2024, time=2024-03-13, status=1, ipAttribution=槟州), GetPortalCommentsPageByObjectIdResponse(id=575120, encodeId=76d15e512048, content=请问大神,投稿的时候就要传已经签名的copyright么?如果投稿的时候没传是不是两周之内要补上?能等编辑给消息了再补copyright吗。还是不传copyright稿件就不会审理?初次投稿,不太懂,感谢前辈的回复<span class="quote">zhangyuanyuan 2017-11-18 10:00:00 发表:<br>9.10号投稿.10.24暂时接收.11.14小修核对.11.17正式接收.总体来说还是很容易中的.虽然分数不高.但是第一篇sci顺利接收.还是很开心的.未来再接再厉!大家如果有消化科科研兴趣的.可以跟我多交流!</span>, beContent=zhangyuanyuan 2017-11-18 10:00:00 发表: 9.10号投稿.10.24暂时接收.11.14小修核对.11.17正式接收.总体来说还是很容易中的.虽然分数不高.但是第一篇sci顺利接收.还是很开心的.未来再接再厉!大家如果有消化科科研兴趣的.可以跟我多交流!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/12/583cfe768bfe1fa945460bb6b687441a.jpg, createdBy=4bcf2195510, createdName=王林林, createdTime=Wed Aug 21 00:00:00 CST 2019, time=2019-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590452, encodeId=d1fb5904524d, content=请问你两周之内补上了吗。我也遇到这个问题怕,谢谢<span class="quote">王林林 2019-08-21 00:00:00 发表:<br>请问一下,如果刚投稿,两周之内没有上传已签名的copyright,。会影响稿件的处理吗?</span>, beContent=王林林 2019-08-21 00:00:00 发表: 请问一下,如果刚投稿,两周之内没有上传已签名的copyright,。会影响稿件的处理吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=560e5151026, createdName=14697858m50(暂无昵称), createdTime=Fri May 08 00:00:00 CST 2020, time=2020-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1213222, encodeId=e0571213222bc, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享:比较好中吧,杂志挺好的<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6e461972408, createdName=罗磊, createdTime=Thu Apr 21 17:33:58 CST 2022, time=2022-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095044, encodeId=d6b920950440d, content=请问copyright怎么上传, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f52b2024392, createdName=爱学习的汪医生, createdTime=Thu Oct 20 21:24:38 CST 2022, time=2022-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2145084, encodeId=75e32145084ee, content=偏重的研究方向:消化性溃疡<br>经验分享:2023.05.11投了一篇meta分析,2023.06.27还没有消息,静待佳音,随时更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=40912029793, createdName=pcr小妹, createdTime=Tue Jun 27 20:57:40 CST 2023, time=2023-06-27, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2161998, encodeId=f1a22161998db, content=偏重的研究方向:慢性肝病研究<br>经验分享:under technical modification 是啥意思有人可以解惑嘛?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=606e8457349, createdName=ms4000001911305314, createdTime=Tue Oct 10 17:02:46 CST 2023, time=2023-10-10, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1208660, encodeId=cdc7120866050, content=偏重的研究方向:消化病<br>经验分享:投了一篇meta,挺好中的。纯生信就是耍流氓,影响别人后续实验的创新性!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=86225692711, createdName=ms6000001891961838, createdTime=Mon Apr 04 22:34:19 CST 2022, time=2022-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106011, encodeId=3e44110601152, content=什么样的图表可以用来发文章?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=)]
    2024-03-13 Latte2024 来自槟州

    非常慢,快4个月了,还在in peer review,问了编辑就说还没收到审稿人意见,为啥不能催催啊,一直耗着

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2194922, encodeId=ffa3219492287, content=审稿速度:4.0 | 投稿命中率:50.0<br>经验分享:11.20投稿.3.21小修,3.23返回,有消息会说。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/iaqwic5175nrsPthItiav2krrGr1HkL2Gl7ibKMfiaxFDfk8ooX2wKVqzMMmDYZEhyD6bNYCouCkTg1zL6EhBr4cRPwH5icBgibpdbQ/0, createdBy=cc4f2072535, createdName=Latte2024, createdTime=Sat Mar 23 21:05:57 CST 2024, time=2024-03-23, status=1, ipAttribution=雪兰莪), GetPortalCommentsPageByObjectIdResponse(id=2192874, encodeId=663021928e4bb, content=非常慢,快4个月了,还在in peer review,问了编辑就说还没收到审稿人意见,为啥不能催催啊,一直耗着, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/iaqwic5175nrsPthItiav2krrGr1HkL2Gl7ibKMfiaxFDfk8ooX2wKVqzMMmDYZEhyD6bNYCouCkTg1zL6EhBr4cRPwH5icBgibpdbQ/0, createdBy=cc4f2072535, createdName=Latte2024, createdTime=Wed Mar 13 00:37:37 CST 2024, time=2024-03-13, status=1, ipAttribution=槟州), GetPortalCommentsPageByObjectIdResponse(id=575120, encodeId=76d15e512048, content=请问大神,投稿的时候就要传已经签名的copyright么?如果投稿的时候没传是不是两周之内要补上?能等编辑给消息了再补copyright吗。还是不传copyright稿件就不会审理?初次投稿,不太懂,感谢前辈的回复<span class="quote">zhangyuanyuan 2017-11-18 10:00:00 发表:<br>9.10号投稿.10.24暂时接收.11.14小修核对.11.17正式接收.总体来说还是很容易中的.虽然分数不高.但是第一篇sci顺利接收.还是很开心的.未来再接再厉!大家如果有消化科科研兴趣的.可以跟我多交流!</span>, beContent=zhangyuanyuan 2017-11-18 10:00:00 发表: 9.10号投稿.10.24暂时接收.11.14小修核对.11.17正式接收.总体来说还是很容易中的.虽然分数不高.但是第一篇sci顺利接收.还是很开心的.未来再接再厉!大家如果有消化科科研兴趣的.可以跟我多交流!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/12/583cfe768bfe1fa945460bb6b687441a.jpg, createdBy=4bcf2195510, createdName=王林林, createdTime=Wed Aug 21 00:00:00 CST 2019, time=2019-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590452, encodeId=d1fb5904524d, content=请问你两周之内补上了吗。我也遇到这个问题怕,谢谢<span class="quote">王林林 2019-08-21 00:00:00 发表:<br>请问一下,如果刚投稿,两周之内没有上传已签名的copyright,。会影响稿件的处理吗?</span>, beContent=王林林 2019-08-21 00:00:00 发表: 请问一下,如果刚投稿,两周之内没有上传已签名的copyright,。会影响稿件的处理吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=560e5151026, createdName=14697858m50(暂无昵称), createdTime=Fri May 08 00:00:00 CST 2020, time=2020-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1213222, encodeId=e0571213222bc, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享:比较好中吧,杂志挺好的<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6e461972408, createdName=罗磊, createdTime=Thu Apr 21 17:33:58 CST 2022, time=2022-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095044, encodeId=d6b920950440d, content=请问copyright怎么上传, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f52b2024392, createdName=爱学习的汪医生, createdTime=Thu Oct 20 21:24:38 CST 2022, time=2022-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2145084, encodeId=75e32145084ee, content=偏重的研究方向:消化性溃疡<br>经验分享:2023.05.11投了一篇meta分析,2023.06.27还没有消息,静待佳音,随时更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=40912029793, createdName=pcr小妹, createdTime=Tue Jun 27 20:57:40 CST 2023, time=2023-06-27, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2161998, encodeId=f1a22161998db, content=偏重的研究方向:慢性肝病研究<br>经验分享:under technical modification 是啥意思有人可以解惑嘛?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=606e8457349, createdName=ms4000001911305314, createdTime=Tue Oct 10 17:02:46 CST 2023, time=2023-10-10, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1208660, encodeId=cdc7120866050, content=偏重的研究方向:消化病<br>经验分享:投了一篇meta,挺好中的。纯生信就是耍流氓,影响别人后续实验的创新性!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=86225692711, createdName=ms6000001891961838, createdTime=Mon Apr 04 22:34:19 CST 2022, time=2022-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106011, encodeId=3e44110601152, content=什么样的图表可以用来发文章?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=)]
    2019-08-21 王林林

    请问大神,投稿的时候就要传已经签名的copyright么?如果投稿的时候没传是不是两周之内要补上?能等编辑给消息了再补copyright吗。还是不传copyright稿件就不会审理?初次投稿,不太懂,感谢前辈的回复zhangyuanyuan 2017-11-18 10:00:00 发表:
    9.10号投稿.10.24暂时接收.11.14小修核对.11.17正式接收.总体来说还是很容易中的.虽然分数不高.但是第一篇sci顺利接收.还是很开心的.未来再接再厉!大家如果有消化科科研兴趣的.可以跟我多交流!

    zhangyuanyuan 2017-11-18 10:00:00 发表: 9.10号投稿.10.24暂时接收.11.14小修核对.11.17正式接收.总体来说还是很容易中的.虽然分数不高.但是第一篇sci顺利接收.还是很开心的.未来再接再厉!大家如果有消化科科研兴趣的.可以跟我多交流!

    2

    展开2条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2194922, encodeId=ffa3219492287, content=审稿速度:4.0 | 投稿命中率:50.0<br>经验分享:11.20投稿.3.21小修,3.23返回,有消息会说。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/iaqwic5175nrsPthItiav2krrGr1HkL2Gl7ibKMfiaxFDfk8ooX2wKVqzMMmDYZEhyD6bNYCouCkTg1zL6EhBr4cRPwH5icBgibpdbQ/0, createdBy=cc4f2072535, createdName=Latte2024, createdTime=Sat Mar 23 21:05:57 CST 2024, time=2024-03-23, status=1, ipAttribution=雪兰莪), GetPortalCommentsPageByObjectIdResponse(id=2192874, encodeId=663021928e4bb, content=非常慢,快4个月了,还在in peer review,问了编辑就说还没收到审稿人意见,为啥不能催催啊,一直耗着, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/iaqwic5175nrsPthItiav2krrGr1HkL2Gl7ibKMfiaxFDfk8ooX2wKVqzMMmDYZEhyD6bNYCouCkTg1zL6EhBr4cRPwH5icBgibpdbQ/0, createdBy=cc4f2072535, createdName=Latte2024, createdTime=Wed Mar 13 00:37:37 CST 2024, time=2024-03-13, status=1, ipAttribution=槟州), GetPortalCommentsPageByObjectIdResponse(id=575120, encodeId=76d15e512048, content=请问大神,投稿的时候就要传已经签名的copyright么?如果投稿的时候没传是不是两周之内要补上?能等编辑给消息了再补copyright吗。还是不传copyright稿件就不会审理?初次投稿,不太懂,感谢前辈的回复<span class="quote">zhangyuanyuan 2017-11-18 10:00:00 发表:<br>9.10号投稿.10.24暂时接收.11.14小修核对.11.17正式接收.总体来说还是很容易中的.虽然分数不高.但是第一篇sci顺利接收.还是很开心的.未来再接再厉!大家如果有消化科科研兴趣的.可以跟我多交流!</span>, beContent=zhangyuanyuan 2017-11-18 10:00:00 发表: 9.10号投稿.10.24暂时接收.11.14小修核对.11.17正式接收.总体来说还是很容易中的.虽然分数不高.但是第一篇sci顺利接收.还是很开心的.未来再接再厉!大家如果有消化科科研兴趣的.可以跟我多交流!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/12/583cfe768bfe1fa945460bb6b687441a.jpg, createdBy=4bcf2195510, createdName=王林林, createdTime=Wed Aug 21 00:00:00 CST 2019, time=2019-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590452, encodeId=d1fb5904524d, content=请问你两周之内补上了吗。我也遇到这个问题怕,谢谢<span class="quote">王林林 2019-08-21 00:00:00 发表:<br>请问一下,如果刚投稿,两周之内没有上传已签名的copyright,。会影响稿件的处理吗?</span>, beContent=王林林 2019-08-21 00:00:00 发表: 请问一下,如果刚投稿,两周之内没有上传已签名的copyright,。会影响稿件的处理吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=560e5151026, createdName=14697858m50(暂无昵称), createdTime=Fri May 08 00:00:00 CST 2020, time=2020-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1213222, encodeId=e0571213222bc, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享:比较好中吧,杂志挺好的<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6e461972408, createdName=罗磊, createdTime=Thu Apr 21 17:33:58 CST 2022, time=2022-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095044, encodeId=d6b920950440d, content=请问copyright怎么上传, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f52b2024392, createdName=爱学习的汪医生, createdTime=Thu Oct 20 21:24:38 CST 2022, time=2022-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2145084, encodeId=75e32145084ee, content=偏重的研究方向:消化性溃疡<br>经验分享:2023.05.11投了一篇meta分析,2023.06.27还没有消息,静待佳音,随时更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=40912029793, createdName=pcr小妹, createdTime=Tue Jun 27 20:57:40 CST 2023, time=2023-06-27, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2161998, encodeId=f1a22161998db, content=偏重的研究方向:慢性肝病研究<br>经验分享:under technical modification 是啥意思有人可以解惑嘛?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=606e8457349, createdName=ms4000001911305314, createdTime=Tue Oct 10 17:02:46 CST 2023, time=2023-10-10, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1208660, encodeId=cdc7120866050, content=偏重的研究方向:消化病<br>经验分享:投了一篇meta,挺好中的。纯生信就是耍流氓,影响别人后续实验的创新性!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=86225692711, createdName=ms6000001891961838, createdTime=Mon Apr 04 22:34:19 CST 2022, time=2022-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106011, encodeId=3e44110601152, content=什么样的图表可以用来发文章?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=)]
    2020-05-08 14697858m50(暂无昵称)

    请问你两周之内补上了吗。我也遇到这个问题怕,谢谢王林林 2019-08-21 00:00:00 发表:
    请问一下,如果刚投稿,两周之内没有上传已签名的copyright,。会影响稿件的处理吗?

    王林林 2019-08-21 00:00:00 发表: 请问一下,如果刚投稿,两周之内没有上传已签名的copyright,。会影响稿件的处理吗?

    3

    展开3条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2194922, encodeId=ffa3219492287, content=审稿速度:4.0 | 投稿命中率:50.0<br>经验分享:11.20投稿.3.21小修,3.23返回,有消息会说。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/iaqwic5175nrsPthItiav2krrGr1HkL2Gl7ibKMfiaxFDfk8ooX2wKVqzMMmDYZEhyD6bNYCouCkTg1zL6EhBr4cRPwH5icBgibpdbQ/0, createdBy=cc4f2072535, createdName=Latte2024, createdTime=Sat Mar 23 21:05:57 CST 2024, time=2024-03-23, status=1, ipAttribution=雪兰莪), GetPortalCommentsPageByObjectIdResponse(id=2192874, encodeId=663021928e4bb, content=非常慢,快4个月了,还在in peer review,问了编辑就说还没收到审稿人意见,为啥不能催催啊,一直耗着, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/iaqwic5175nrsPthItiav2krrGr1HkL2Gl7ibKMfiaxFDfk8ooX2wKVqzMMmDYZEhyD6bNYCouCkTg1zL6EhBr4cRPwH5icBgibpdbQ/0, createdBy=cc4f2072535, createdName=Latte2024, createdTime=Wed Mar 13 00:37:37 CST 2024, time=2024-03-13, status=1, ipAttribution=槟州), GetPortalCommentsPageByObjectIdResponse(id=575120, encodeId=76d15e512048, content=请问大神,投稿的时候就要传已经签名的copyright么?如果投稿的时候没传是不是两周之内要补上?能等编辑给消息了再补copyright吗。还是不传copyright稿件就不会审理?初次投稿,不太懂,感谢前辈的回复<span class="quote">zhangyuanyuan 2017-11-18 10:00:00 发表:<br>9.10号投稿.10.24暂时接收.11.14小修核对.11.17正式接收.总体来说还是很容易中的.虽然分数不高.但是第一篇sci顺利接收.还是很开心的.未来再接再厉!大家如果有消化科科研兴趣的.可以跟我多交流!</span>, beContent=zhangyuanyuan 2017-11-18 10:00:00 发表: 9.10号投稿.10.24暂时接收.11.14小修核对.11.17正式接收.总体来说还是很容易中的.虽然分数不高.但是第一篇sci顺利接收.还是很开心的.未来再接再厉!大家如果有消化科科研兴趣的.可以跟我多交流!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/12/583cfe768bfe1fa945460bb6b687441a.jpg, createdBy=4bcf2195510, createdName=王林林, createdTime=Wed Aug 21 00:00:00 CST 2019, time=2019-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590452, encodeId=d1fb5904524d, content=请问你两周之内补上了吗。我也遇到这个问题怕,谢谢<span class="quote">王林林 2019-08-21 00:00:00 发表:<br>请问一下,如果刚投稿,两周之内没有上传已签名的copyright,。会影响稿件的处理吗?</span>, beContent=王林林 2019-08-21 00:00:00 发表: 请问一下,如果刚投稿,两周之内没有上传已签名的copyright,。会影响稿件的处理吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=560e5151026, createdName=14697858m50(暂无昵称), createdTime=Fri May 08 00:00:00 CST 2020, time=2020-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1213222, encodeId=e0571213222bc, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享:比较好中吧,杂志挺好的<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6e461972408, createdName=罗磊, createdTime=Thu Apr 21 17:33:58 CST 2022, time=2022-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095044, encodeId=d6b920950440d, content=请问copyright怎么上传, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f52b2024392, createdName=爱学习的汪医生, createdTime=Thu Oct 20 21:24:38 CST 2022, time=2022-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2145084, encodeId=75e32145084ee, content=偏重的研究方向:消化性溃疡<br>经验分享:2023.05.11投了一篇meta分析,2023.06.27还没有消息,静待佳音,随时更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=40912029793, createdName=pcr小妹, createdTime=Tue Jun 27 20:57:40 CST 2023, time=2023-06-27, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2161998, encodeId=f1a22161998db, content=偏重的研究方向:慢性肝病研究<br>经验分享:under technical modification 是啥意思有人可以解惑嘛?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=606e8457349, createdName=ms4000001911305314, createdTime=Tue Oct 10 17:02:46 CST 2023, time=2023-10-10, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1208660, encodeId=cdc7120866050, content=偏重的研究方向:消化病<br>经验分享:投了一篇meta,挺好中的。纯生信就是耍流氓,影响别人后续实验的创新性!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=86225692711, createdName=ms6000001891961838, createdTime=Mon Apr 04 22:34:19 CST 2022, time=2022-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106011, encodeId=3e44110601152, content=什么样的图表可以用来发文章?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=)]
    2022-04-21 罗磊

    审稿速度:1.0 | 投稿命中率:75.0
    经验分享:比较好中吧,杂志挺好的

    8

    展开8条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2194922, encodeId=ffa3219492287, content=审稿速度:4.0 | 投稿命中率:50.0<br>经验分享:11.20投稿.3.21小修,3.23返回,有消息会说。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/iaqwic5175nrsPthItiav2krrGr1HkL2Gl7ibKMfiaxFDfk8ooX2wKVqzMMmDYZEhyD6bNYCouCkTg1zL6EhBr4cRPwH5icBgibpdbQ/0, createdBy=cc4f2072535, createdName=Latte2024, createdTime=Sat Mar 23 21:05:57 CST 2024, time=2024-03-23, status=1, ipAttribution=雪兰莪), GetPortalCommentsPageByObjectIdResponse(id=2192874, encodeId=663021928e4bb, content=非常慢,快4个月了,还在in peer review,问了编辑就说还没收到审稿人意见,为啥不能催催啊,一直耗着, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/iaqwic5175nrsPthItiav2krrGr1HkL2Gl7ibKMfiaxFDfk8ooX2wKVqzMMmDYZEhyD6bNYCouCkTg1zL6EhBr4cRPwH5icBgibpdbQ/0, createdBy=cc4f2072535, createdName=Latte2024, createdTime=Wed Mar 13 00:37:37 CST 2024, time=2024-03-13, status=1, ipAttribution=槟州), GetPortalCommentsPageByObjectIdResponse(id=575120, encodeId=76d15e512048, content=请问大神,投稿的时候就要传已经签名的copyright么?如果投稿的时候没传是不是两周之内要补上?能等编辑给消息了再补copyright吗。还是不传copyright稿件就不会审理?初次投稿,不太懂,感谢前辈的回复<span class="quote">zhangyuanyuan 2017-11-18 10:00:00 发表:<br>9.10号投稿.10.24暂时接收.11.14小修核对.11.17正式接收.总体来说还是很容易中的.虽然分数不高.但是第一篇sci顺利接收.还是很开心的.未来再接再厉!大家如果有消化科科研兴趣的.可以跟我多交流!</span>, beContent=zhangyuanyuan 2017-11-18 10:00:00 发表: 9.10号投稿.10.24暂时接收.11.14小修核对.11.17正式接收.总体来说还是很容易中的.虽然分数不高.但是第一篇sci顺利接收.还是很开心的.未来再接再厉!大家如果有消化科科研兴趣的.可以跟我多交流!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/12/583cfe768bfe1fa945460bb6b687441a.jpg, createdBy=4bcf2195510, createdName=王林林, createdTime=Wed Aug 21 00:00:00 CST 2019, time=2019-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590452, encodeId=d1fb5904524d, content=请问你两周之内补上了吗。我也遇到这个问题怕,谢谢<span class="quote">王林林 2019-08-21 00:00:00 发表:<br>请问一下,如果刚投稿,两周之内没有上传已签名的copyright,。会影响稿件的处理吗?</span>, beContent=王林林 2019-08-21 00:00:00 发表: 请问一下,如果刚投稿,两周之内没有上传已签名的copyright,。会影响稿件的处理吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=560e5151026, createdName=14697858m50(暂无昵称), createdTime=Fri May 08 00:00:00 CST 2020, time=2020-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1213222, encodeId=e0571213222bc, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享:比较好中吧,杂志挺好的<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6e461972408, createdName=罗磊, createdTime=Thu Apr 21 17:33:58 CST 2022, time=2022-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095044, encodeId=d6b920950440d, content=请问copyright怎么上传, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f52b2024392, createdName=爱学习的汪医生, createdTime=Thu Oct 20 21:24:38 CST 2022, time=2022-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2145084, encodeId=75e32145084ee, content=偏重的研究方向:消化性溃疡<br>经验分享:2023.05.11投了一篇meta分析,2023.06.27还没有消息,静待佳音,随时更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=40912029793, createdName=pcr小妹, createdTime=Tue Jun 27 20:57:40 CST 2023, time=2023-06-27, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2161998, encodeId=f1a22161998db, content=偏重的研究方向:慢性肝病研究<br>经验分享:under technical modification 是啥意思有人可以解惑嘛?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=606e8457349, createdName=ms4000001911305314, createdTime=Tue Oct 10 17:02:46 CST 2023, time=2023-10-10, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1208660, encodeId=cdc7120866050, content=偏重的研究方向:消化病<br>经验分享:投了一篇meta,挺好中的。纯生信就是耍流氓,影响别人后续实验的创新性!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=86225692711, createdName=ms6000001891961838, createdTime=Mon Apr 04 22:34:19 CST 2022, time=2022-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106011, encodeId=3e44110601152, content=什么样的图表可以用来发文章?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=)]
    2022-10-20 爱学习的汪医生

    请问copyright怎么上传

    3

    展开3条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2194922, encodeId=ffa3219492287, content=审稿速度:4.0 | 投稿命中率:50.0<br>经验分享:11.20投稿.3.21小修,3.23返回,有消息会说。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/iaqwic5175nrsPthItiav2krrGr1HkL2Gl7ibKMfiaxFDfk8ooX2wKVqzMMmDYZEhyD6bNYCouCkTg1zL6EhBr4cRPwH5icBgibpdbQ/0, createdBy=cc4f2072535, createdName=Latte2024, createdTime=Sat Mar 23 21:05:57 CST 2024, time=2024-03-23, status=1, ipAttribution=雪兰莪), GetPortalCommentsPageByObjectIdResponse(id=2192874, encodeId=663021928e4bb, content=非常慢,快4个月了,还在in peer review,问了编辑就说还没收到审稿人意见,为啥不能催催啊,一直耗着, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/iaqwic5175nrsPthItiav2krrGr1HkL2Gl7ibKMfiaxFDfk8ooX2wKVqzMMmDYZEhyD6bNYCouCkTg1zL6EhBr4cRPwH5icBgibpdbQ/0, createdBy=cc4f2072535, createdName=Latte2024, createdTime=Wed Mar 13 00:37:37 CST 2024, time=2024-03-13, status=1, ipAttribution=槟州), GetPortalCommentsPageByObjectIdResponse(id=575120, encodeId=76d15e512048, content=请问大神,投稿的时候就要传已经签名的copyright么?如果投稿的时候没传是不是两周之内要补上?能等编辑给消息了再补copyright吗。还是不传copyright稿件就不会审理?初次投稿,不太懂,感谢前辈的回复<span class="quote">zhangyuanyuan 2017-11-18 10:00:00 发表:<br>9.10号投稿.10.24暂时接收.11.14小修核对.11.17正式接收.总体来说还是很容易中的.虽然分数不高.但是第一篇sci顺利接收.还是很开心的.未来再接再厉!大家如果有消化科科研兴趣的.可以跟我多交流!</span>, beContent=zhangyuanyuan 2017-11-18 10:00:00 发表: 9.10号投稿.10.24暂时接收.11.14小修核对.11.17正式接收.总体来说还是很容易中的.虽然分数不高.但是第一篇sci顺利接收.还是很开心的.未来再接再厉!大家如果有消化科科研兴趣的.可以跟我多交流!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/12/583cfe768bfe1fa945460bb6b687441a.jpg, createdBy=4bcf2195510, createdName=王林林, createdTime=Wed Aug 21 00:00:00 CST 2019, time=2019-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590452, encodeId=d1fb5904524d, content=请问你两周之内补上了吗。我也遇到这个问题怕,谢谢<span class="quote">王林林 2019-08-21 00:00:00 发表:<br>请问一下,如果刚投稿,两周之内没有上传已签名的copyright,。会影响稿件的处理吗?</span>, beContent=王林林 2019-08-21 00:00:00 发表: 请问一下,如果刚投稿,两周之内没有上传已签名的copyright,。会影响稿件的处理吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=560e5151026, createdName=14697858m50(暂无昵称), createdTime=Fri May 08 00:00:00 CST 2020, time=2020-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1213222, encodeId=e0571213222bc, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享:比较好中吧,杂志挺好的<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6e461972408, createdName=罗磊, createdTime=Thu Apr 21 17:33:58 CST 2022, time=2022-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095044, encodeId=d6b920950440d, content=请问copyright怎么上传, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f52b2024392, createdName=爱学习的汪医生, createdTime=Thu Oct 20 21:24:38 CST 2022, time=2022-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2145084, encodeId=75e32145084ee, content=偏重的研究方向:消化性溃疡<br>经验分享:2023.05.11投了一篇meta分析,2023.06.27还没有消息,静待佳音,随时更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=40912029793, createdName=pcr小妹, createdTime=Tue Jun 27 20:57:40 CST 2023, time=2023-06-27, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2161998, encodeId=f1a22161998db, content=偏重的研究方向:慢性肝病研究<br>经验分享:under technical modification 是啥意思有人可以解惑嘛?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=606e8457349, createdName=ms4000001911305314, createdTime=Tue Oct 10 17:02:46 CST 2023, time=2023-10-10, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1208660, encodeId=cdc7120866050, content=偏重的研究方向:消化病<br>经验分享:投了一篇meta,挺好中的。纯生信就是耍流氓,影响别人后续实验的创新性!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=86225692711, createdName=ms6000001891961838, createdTime=Mon Apr 04 22:34:19 CST 2022, time=2022-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106011, encodeId=3e44110601152, content=什么样的图表可以用来发文章?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=)]
    2023-06-27 pcr小妹 来自四川省

    偏重的研究方向:消化性溃疡
    经验分享:2023.05.11投了一篇meta分析,2023.06.27还没有消息,静待佳音,随时更新

    1

    展开1条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2194922, encodeId=ffa3219492287, content=审稿速度:4.0 | 投稿命中率:50.0<br>经验分享:11.20投稿.3.21小修,3.23返回,有消息会说。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/iaqwic5175nrsPthItiav2krrGr1HkL2Gl7ibKMfiaxFDfk8ooX2wKVqzMMmDYZEhyD6bNYCouCkTg1zL6EhBr4cRPwH5icBgibpdbQ/0, createdBy=cc4f2072535, createdName=Latte2024, createdTime=Sat Mar 23 21:05:57 CST 2024, time=2024-03-23, status=1, ipAttribution=雪兰莪), GetPortalCommentsPageByObjectIdResponse(id=2192874, encodeId=663021928e4bb, content=非常慢,快4个月了,还在in peer review,问了编辑就说还没收到审稿人意见,为啥不能催催啊,一直耗着, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/iaqwic5175nrsPthItiav2krrGr1HkL2Gl7ibKMfiaxFDfk8ooX2wKVqzMMmDYZEhyD6bNYCouCkTg1zL6EhBr4cRPwH5icBgibpdbQ/0, createdBy=cc4f2072535, createdName=Latte2024, createdTime=Wed Mar 13 00:37:37 CST 2024, time=2024-03-13, status=1, ipAttribution=槟州), GetPortalCommentsPageByObjectIdResponse(id=575120, encodeId=76d15e512048, content=请问大神,投稿的时候就要传已经签名的copyright么?如果投稿的时候没传是不是两周之内要补上?能等编辑给消息了再补copyright吗。还是不传copyright稿件就不会审理?初次投稿,不太懂,感谢前辈的回复<span class="quote">zhangyuanyuan 2017-11-18 10:00:00 发表:<br>9.10号投稿.10.24暂时接收.11.14小修核对.11.17正式接收.总体来说还是很容易中的.虽然分数不高.但是第一篇sci顺利接收.还是很开心的.未来再接再厉!大家如果有消化科科研兴趣的.可以跟我多交流!</span>, beContent=zhangyuanyuan 2017-11-18 10:00:00 发表: 9.10号投稿.10.24暂时接收.11.14小修核对.11.17正式接收.总体来说还是很容易中的.虽然分数不高.但是第一篇sci顺利接收.还是很开心的.未来再接再厉!大家如果有消化科科研兴趣的.可以跟我多交流!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/12/583cfe768bfe1fa945460bb6b687441a.jpg, createdBy=4bcf2195510, createdName=王林林, createdTime=Wed Aug 21 00:00:00 CST 2019, time=2019-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590452, encodeId=d1fb5904524d, content=请问你两周之内补上了吗。我也遇到这个问题怕,谢谢<span class="quote">王林林 2019-08-21 00:00:00 发表:<br>请问一下,如果刚投稿,两周之内没有上传已签名的copyright,。会影响稿件的处理吗?</span>, beContent=王林林 2019-08-21 00:00:00 发表: 请问一下,如果刚投稿,两周之内没有上传已签名的copyright,。会影响稿件的处理吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=560e5151026, createdName=14697858m50(暂无昵称), createdTime=Fri May 08 00:00:00 CST 2020, time=2020-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1213222, encodeId=e0571213222bc, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享:比较好中吧,杂志挺好的<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6e461972408, createdName=罗磊, createdTime=Thu Apr 21 17:33:58 CST 2022, time=2022-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095044, encodeId=d6b920950440d, content=请问copyright怎么上传, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f52b2024392, createdName=爱学习的汪医生, createdTime=Thu Oct 20 21:24:38 CST 2022, time=2022-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2145084, encodeId=75e32145084ee, content=偏重的研究方向:消化性溃疡<br>经验分享:2023.05.11投了一篇meta分析,2023.06.27还没有消息,静待佳音,随时更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=40912029793, createdName=pcr小妹, createdTime=Tue Jun 27 20:57:40 CST 2023, time=2023-06-27, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2161998, encodeId=f1a22161998db, content=偏重的研究方向:慢性肝病研究<br>经验分享:under technical modification 是啥意思有人可以解惑嘛?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=606e8457349, createdName=ms4000001911305314, createdTime=Tue Oct 10 17:02:46 CST 2023, time=2023-10-10, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1208660, encodeId=cdc7120866050, content=偏重的研究方向:消化病<br>经验分享:投了一篇meta,挺好中的。纯生信就是耍流氓,影响别人后续实验的创新性!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=86225692711, createdName=ms6000001891961838, createdTime=Mon Apr 04 22:34:19 CST 2022, time=2022-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106011, encodeId=3e44110601152, content=什么样的图表可以用来发文章?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=)]
    2023-10-10 ms4000001911305314 来自山东省

    偏重的研究方向:慢性肝病研究
    经验分享:under technical modification 是啥意思有人可以解惑嘛?

    1

    展开1条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=2194922, encodeId=ffa3219492287, content=审稿速度:4.0 | 投稿命中率:50.0<br>经验分享:11.20投稿.3.21小修,3.23返回,有消息会说。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/iaqwic5175nrsPthItiav2krrGr1HkL2Gl7ibKMfiaxFDfk8ooX2wKVqzMMmDYZEhyD6bNYCouCkTg1zL6EhBr4cRPwH5icBgibpdbQ/0, createdBy=cc4f2072535, createdName=Latte2024, createdTime=Sat Mar 23 21:05:57 CST 2024, time=2024-03-23, status=1, ipAttribution=雪兰莪), GetPortalCommentsPageByObjectIdResponse(id=2192874, encodeId=663021928e4bb, content=非常慢,快4个月了,还在in peer review,问了编辑就说还没收到审稿人意见,为啥不能催催啊,一直耗着, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/iaqwic5175nrsPthItiav2krrGr1HkL2Gl7ibKMfiaxFDfk8ooX2wKVqzMMmDYZEhyD6bNYCouCkTg1zL6EhBr4cRPwH5icBgibpdbQ/0, createdBy=cc4f2072535, createdName=Latte2024, createdTime=Wed Mar 13 00:37:37 CST 2024, time=2024-03-13, status=1, ipAttribution=槟州), GetPortalCommentsPageByObjectIdResponse(id=575120, encodeId=76d15e512048, content=请问大神,投稿的时候就要传已经签名的copyright么?如果投稿的时候没传是不是两周之内要补上?能等编辑给消息了再补copyright吗。还是不传copyright稿件就不会审理?初次投稿,不太懂,感谢前辈的回复<span class="quote">zhangyuanyuan 2017-11-18 10:00:00 发表:<br>9.10号投稿.10.24暂时接收.11.14小修核对.11.17正式接收.总体来说还是很容易中的.虽然分数不高.但是第一篇sci顺利接收.还是很开心的.未来再接再厉!大家如果有消化科科研兴趣的.可以跟我多交流!</span>, beContent=zhangyuanyuan 2017-11-18 10:00:00 发表: 9.10号投稿.10.24暂时接收.11.14小修核对.11.17正式接收.总体来说还是很容易中的.虽然分数不高.但是第一篇sci顺利接收.还是很开心的.未来再接再厉!大家如果有消化科科研兴趣的.可以跟我多交流!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/12/583cfe768bfe1fa945460bb6b687441a.jpg, createdBy=4bcf2195510, createdName=王林林, createdTime=Wed Aug 21 00:00:00 CST 2019, time=2019-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590452, encodeId=d1fb5904524d, content=请问你两周之内补上了吗。我也遇到这个问题怕,谢谢<span class="quote">王林林 2019-08-21 00:00:00 发表:<br>请问一下,如果刚投稿,两周之内没有上传已签名的copyright,。会影响稿件的处理吗?</span>, beContent=王林林 2019-08-21 00:00:00 发表: 请问一下,如果刚投稿,两周之内没有上传已签名的copyright,。会影响稿件的处理吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=560e5151026, createdName=14697858m50(暂无昵称), createdTime=Fri May 08 00:00:00 CST 2020, time=2020-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1213222, encodeId=e0571213222bc, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享:比较好中吧,杂志挺好的<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6e461972408, createdName=罗磊, createdTime=Thu Apr 21 17:33:58 CST 2022, time=2022-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095044, encodeId=d6b920950440d, content=请问copyright怎么上传, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f52b2024392, createdName=爱学习的汪医生, createdTime=Thu Oct 20 21:24:38 CST 2022, time=2022-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2145084, encodeId=75e32145084ee, content=偏重的研究方向:消化性溃疡<br>经验分享:2023.05.11投了一篇meta分析,2023.06.27还没有消息,静待佳音,随时更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=40912029793, createdName=pcr小妹, createdTime=Tue Jun 27 20:57:40 CST 2023, time=2023-06-27, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2161998, encodeId=f1a22161998db, content=偏重的研究方向:慢性肝病研究<br>经验分享:under technical modification 是啥意思有人可以解惑嘛?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=606e8457349, createdName=ms4000001911305314, createdTime=Tue Oct 10 17:02:46 CST 2023, time=2023-10-10, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1208660, encodeId=cdc7120866050, content=偏重的研究方向:消化病<br>经验分享:投了一篇meta,挺好中的。纯生信就是耍流氓,影响别人后续实验的创新性!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=86225692711, createdName=ms6000001891961838, createdTime=Mon Apr 04 22:34:19 CST 2022, time=2022-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106011, encodeId=3e44110601152, content=什么样的图表可以用来发文章?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=)]
    2022-04-04 ms6000001891961838

    偏重的研究方向:消化病
    经验分享:投了一篇meta,挺好中的。纯生信就是耍流氓,影响别人后续实验的创新性!

    2

    展开2条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=2194922, encodeId=ffa3219492287, content=审稿速度:4.0 | 投稿命中率:50.0<br>经验分享:11.20投稿.3.21小修,3.23返回,有消息会说。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/iaqwic5175nrsPthItiav2krrGr1HkL2Gl7ibKMfiaxFDfk8ooX2wKVqzMMmDYZEhyD6bNYCouCkTg1zL6EhBr4cRPwH5icBgibpdbQ/0, createdBy=cc4f2072535, createdName=Latte2024, createdTime=Sat Mar 23 21:05:57 CST 2024, time=2024-03-23, status=1, ipAttribution=雪兰莪), GetPortalCommentsPageByObjectIdResponse(id=2192874, encodeId=663021928e4bb, content=非常慢,快4个月了,还在in peer review,问了编辑就说还没收到审稿人意见,为啥不能催催啊,一直耗着, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/iaqwic5175nrsPthItiav2krrGr1HkL2Gl7ibKMfiaxFDfk8ooX2wKVqzMMmDYZEhyD6bNYCouCkTg1zL6EhBr4cRPwH5icBgibpdbQ/0, createdBy=cc4f2072535, createdName=Latte2024, createdTime=Wed Mar 13 00:37:37 CST 2024, time=2024-03-13, status=1, ipAttribution=槟州), GetPortalCommentsPageByObjectIdResponse(id=575120, encodeId=76d15e512048, content=请问大神,投稿的时候就要传已经签名的copyright么?如果投稿的时候没传是不是两周之内要补上?能等编辑给消息了再补copyright吗。还是不传copyright稿件就不会审理?初次投稿,不太懂,感谢前辈的回复<span class="quote">zhangyuanyuan 2017-11-18 10:00:00 发表:<br>9.10号投稿.10.24暂时接收.11.14小修核对.11.17正式接收.总体来说还是很容易中的.虽然分数不高.但是第一篇sci顺利接收.还是很开心的.未来再接再厉!大家如果有消化科科研兴趣的.可以跟我多交流!</span>, beContent=zhangyuanyuan 2017-11-18 10:00:00 发表: 9.10号投稿.10.24暂时接收.11.14小修核对.11.17正式接收.总体来说还是很容易中的.虽然分数不高.但是第一篇sci顺利接收.还是很开心的.未来再接再厉!大家如果有消化科科研兴趣的.可以跟我多交流!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/12/583cfe768bfe1fa945460bb6b687441a.jpg, createdBy=4bcf2195510, createdName=王林林, createdTime=Wed Aug 21 00:00:00 CST 2019, time=2019-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590452, encodeId=d1fb5904524d, content=请问你两周之内补上了吗。我也遇到这个问题怕,谢谢<span class="quote">王林林 2019-08-21 00:00:00 发表:<br>请问一下,如果刚投稿,两周之内没有上传已签名的copyright,。会影响稿件的处理吗?</span>, beContent=王林林 2019-08-21 00:00:00 发表: 请问一下,如果刚投稿,两周之内没有上传已签名的copyright,。会影响稿件的处理吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=560e5151026, createdName=14697858m50(暂无昵称), createdTime=Fri May 08 00:00:00 CST 2020, time=2020-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1213222, encodeId=e0571213222bc, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享:比较好中吧,杂志挺好的<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6e461972408, createdName=罗磊, createdTime=Thu Apr 21 17:33:58 CST 2022, time=2022-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095044, encodeId=d6b920950440d, content=请问copyright怎么上传, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f52b2024392, createdName=爱学习的汪医生, createdTime=Thu Oct 20 21:24:38 CST 2022, time=2022-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2145084, encodeId=75e32145084ee, content=偏重的研究方向:消化性溃疡<br>经验分享:2023.05.11投了一篇meta分析,2023.06.27还没有消息,静待佳音,随时更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=40912029793, createdName=pcr小妹, createdTime=Tue Jun 27 20:57:40 CST 2023, time=2023-06-27, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2161998, encodeId=f1a22161998db, content=偏重的研究方向:慢性肝病研究<br>经验分享:under technical modification 是啥意思有人可以解惑嘛?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=606e8457349, createdName=ms4000001911305314, createdTime=Tue Oct 10 17:02:46 CST 2023, time=2023-10-10, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1208660, encodeId=cdc7120866050, content=偏重的研究方向:消化病<br>经验分享:投了一篇meta,挺好中的。纯生信就是耍流氓,影响别人后续实验的创新性!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=86225692711, createdName=ms6000001891961838, createdTime=Mon Apr 04 22:34:19 CST 2022, time=2022-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106011, encodeId=3e44110601152, content=什么样的图表可以用来发文章?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=)]
    2021-12-28 学医的彭于晏

    什么样的图表可以用来发文章?

    1

    展开1条回复
共76条页码: 1/8页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分